Dermatology

Check out these dermatologic cases as well as take a look at dermatologic signs of COVID-19

Diagnosing multisystem inflammatory syndrome in children (MIS-C) has not always been easy. A new report indicates that mucocutaneous findings might aid in diagnosis.

A healthy 16-year-old girl presented with asymptomatic lesions she had at birth. Examination revealed a 15 cm well-demarcated light brown hyperpigmented background patch localized to the right inguinal skin-fold and, within it, café-au-lait macules and patches, greater than 1.5 cm, with diffuse freckling.

Dermatologic findings in the age of COVID-19, plus lots more at the 2020 American Academy of Pediatrics National Conference & Exhibition.

A 15-year-old male first noticed the marks on his back during a recent vertical growth spurt. On exam there are multiple horizontal violaceous linear striae on his back. He is otherwise healthy and denies any history of back injury or exposure to topical or systemic steroids. What's the diagnosis?

An extensive literature review looks at the dermatoses that are connected to video game play.

Growing evidence indicates that COVID-19 impacts more than the respiratory system. Clinicians should keep an eye out for dermatologic conditions that may be associated with the illness.

Three case studies look at the efficacy of using foreskin for syndactyly repair.

You are asked to evaluate a healthy 19-month-old boy with a history of recurrent blisters on his arms and legs for over a year that have now spread to his face. The blisters scab over quickly, ulcerate, and heal with post-inflammatory pigmentary changes. What's the diagnosis?

COVID-19 has been seen as primarily a disease impacting the lungs, but more of the body's systems have been shown to be impacted by the disease. Here's a look at how the disease impacts the skin.

The US Food and Drug Administration (FDA) has approved STELARA for treating moderate-to-severe plaque psoriasis in children.

Atopic dermatitis treatment has dramatically changed over the years. Here’s a look at the current options.

A healthy 11-day-old male infant is brought to the pediatric clinic for evaluation of rash. The rash started with a 2-mm papule on the left medial epicanthal fold 4 days before the clinic visit. A day before coming to the clinic, the rash had spread to the upper left eyelid and the nasal bridge. What's the diagnosis?

A 16-year-old girl presents for evaluation of a rash on her left forearm, which was 2 enlarging red areas that became increasingly pruritic and edematous. What's the diagnosis?

A recent Danish study examines the connection between body mass index (BMI) and the risk of developing hidradenitis suppurativa in adulthood.

The parents of a healthy 20-month-old boy ask for advice about a birthmark on his lower back. The lesion is asymptomatic and has grown proportionately with their son. What's the diagnosis?

The US Food and Drug Administration has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years.

A new investigation looks at the safety of psoriasis treatment in pediatric cases.

Teenagers like to spend time in the sun and even engage in tanning, in spite of warnings about skin cancer and aging. A new study indicates that using technology could help change adolescent minds.

A healthy 11-year-old boy presents for evaluation of thick skin over the metacarpal (MCP) and proximal interphalangeal (PIP) joints on his right hand. What's the diagnosis?

Anxious parents present their healthy 9-year-old son for evaluation of a slowly enlarging plaque that began developing on his lower back 3 months ago. What's the diagnosis?

The US Food and Drug Administration has approved ixekizumab (Taltz, Eli Lilly) injection, 80 mg/mL, for use in pediatric patients to treat moderate-to-severe plaque psoriasis. The approval means that the drug is the first interleukin 17A (IL-17A) agent available for use in pediatric patients.

The US Food and Drug Administration has given approval for a supplemental new drug application for Eucrisa (crisaborole) that allows the nonsteroidal topical ointment to be used for treating mild-to-moderate atopic dermatitis (AD) in children aged as young as 3 months.

The parents of a healthy 8-year-old girl are worried about an asymptomatic red spot on their daughter’s left cheek that has been enlarging for more than a year. What's the diagnosis?

A 4-year-old boy presents for evaluation with painful swollen fingers on both hands that erupted after he made a snowman with his siblings following a snowstorm. He complains that they are itchy and painful. What's the diagnosis?